Inactive Instrument
ViaDerma, Inc. Share Price Other OTC
Stocks
VDRM
US92555K1016
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 6.31M 5.51M 5.08M 4.69M 8.83M 607M 9.03M 60.78M 23.91M 297M 23.68M 23.16M 1.02B | P/E 2015 |
10.7x | P/E 2016 | -3.3x |
|---|---|---|---|---|---|
| Enterprise Value | 6.6M 5.77M 5.32M 4.91M 9.25M 636M 9.46M 63.64M 25.03M 311M 24.8M 24.25M 1.07B | EV / Sales 2015 |
1.5x | EV / Sales 2016 | 3.63x |
| Free-Float |
99% | Yield 2015 * |
-
| Yield 2016 | - |
| 1 day | +5.85% |
| Manager | Title | Age | Since |
|---|---|---|---|
Chris Ayo Otiko
CEO | Chief Executive Officer | - | 30/03/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
Chris Ayo Otiko
CHM | Chairman | - | 30/03/2014 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +5.85% | -24.07% | - | - | 493K | ||
| -1.29% | -3.11% | -0.35% | +2.64% | 49.18B | ||
| +3.90% | -0.39% | +386.06% | +588.97% | 39.58B | ||
| -1.70% | +4.46% | +5.93% | +61.54% | 34.69B | ||
| -2.01% | -0.76% | +28.41% | -8.52% | 34.42B | ||
| +0.06% | +0.34% | +2.38% | +34.47% | 27.11B | ||
| +0.46% | -3.49% | - | - | 16.21B | ||
| -0.04% | -0.09% | +72.42% | +116.45% | 15.36B | ||
| +1.12% | +1.91% | +14.54% | +15.44% | 14.05B | ||
| 0.00% | +1.36% | +18.43% | -31.23% | 13.02B | ||
| Average | +0.63% | +0.03% | +65.98% | +97.47% | 27.07B | |
| Weighted average by Cap. | -0.05% | -0.18% | +79.44% | +122.31% |
| 2015 | 2016 | |
|---|---|---|
| Net sales | 192K 168K 155K 143K 269K 18.47M 275K 1.85M 727K 9.05M 720K 704K 31.14M | 252K 220K 203K 187K 353K 24.27M 361K 2.43M 955K 11.88M 946K 926K 40.91M |
| Net income | 27.12K 23.7K 21.87K 20.16K 38K 2.61M 38.84K 261K 103K 1.28M 102K 99.62K 4.4M | -122K -106K -98.23K -90.54K -171K -11.73M -174K -1.17M -462K -5.74M -457K -447K -19.78M |
| Net Debt | 288K 252K 232K 214K 404K 27.76M 413K 2.78M 1.09M 13.59M 1.08M 1.06M 46.8M | 297K 259K 239K 221K 416K 28.58M 425K 2.86M 1.13M 14M 1.11M 1.09M 48.19M |
Employees
-
















